Variation in relative risk of venous thromboembolism in different cancers

Thrombosis and Haemostasis

Volumn 87, Issue 6, 2002, Pages 1076-1077

  Thodiyil, P A ^a   Kakkar, A K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANALYSIS OF VARIANCE; BILE DUCT CARCINOMA; CANCER; COMORBIDITY; DEEP VEIN THROMBOSIS; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; LETTER; LEUKEMIA; LUNG EMBOLISM; LYMPHOMA; OVARY CARCINOMA; PREVALENCE; PRIORITY JOURNAL; STOMACH CARCINOMA; SWEDEN; THROMBOEMBOLISM; AGED; INFORMATION PROCESSING; NEOPLASM; PATHOLOGY; RISK; VEIN THROMBOSIS;

AGED; DATA COLLECTION; HUMANS; NEOPLASMS; RISK; SWEDEN; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0036278814     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613136     Document Type: Letter

References (5)

1. Prevalence of pulmonary embolism at necropsy in patients with cancer
2. Venous thromboembolism and cancer
3. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data
4. Trends in the incidence of deep vein thrombosis and pulmonary embolism
5. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism